TCL Archive In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements February 19, 1988
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy February 6, 2009
TCL Archive Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill September 27, 1996
